Clinical trial NCT01482338 - References

Premenstrual Syndrome — Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone

Citation(s)

•   Kurshan N, Neill Epperson C
  Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Womens Ment Health. 2006 Jan;9(1):1-14. Epub 2005 Oct 5. Review.
•   Lopez LM, Kaptein AA, Helmerhorst FM
  Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD006586.
•   Moos RH
  Typology of menstrual cycle symptoms. Am J Obstet Gynecol. 1969 Feb 1;103(3):390-402.
•   New PMS guidelines released
  Recommendations focus on diagnosis and treatment. AWHONN Lifelines. 2000 Jun-Jul;4(3):61-2.
•   Paoletti AM, Lello S, Fratta S, Orrù M, Ranuzzi F, Sogliano C, Concas A, Biggio G, Melis GB
  Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol. Fertil Steril. 2004 Mar;81(3):645-51.
•   Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA
  Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005 Dec;72(6):414-21. Epub 2005 Nov 2.
•   Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B
  Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception. 1996 Aug;54(2):71-7.
•   Sulak PJ, Carl J, Gopalakrishnan I, Coffee A, Kuehl TJ
  Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception. 2004 Oct;70(4):281-7.
•   Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ
  Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol. 2000 Feb;95(2):261-6.
•   Sveindóttir H, Bäckström T
  Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand. 2000 May;79(5):405-13.
•   Tuckwell P
  Schooling the subnormal child. The Massachusetts System. Nurs Mirror Midwives J. 1975 Sep 18;141(12):73-4.
•   Winer SA, Rapkin AJ
  Premenstrual disorders: prevalence, etiology and impact. J Reprod Med. 2006 Apr;51(4 Suppl):339-47. Review.
•   Winkler UH, Ferguson H, Mulders JA
  Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. Contraception. 2004 Jun;69(6):469-76.

A Comparative Efficacy of Low-dose Combine Oral Contraceptives Containing Desogestrel 150 mg and Drospirenone 3 mg on Premenstrual Symptoms

Details for clinical trial NCT01482338